News – Page 77 – Endpoints News

Pfizer partners with two more Flagship biotechs on obesity, cancer

6 months ago

GSK plots regulatory filings for PBC itch after positive Phase 3 readout

6 months ago

NICE has 'done all we can' to negotiate for Enhertu coverage, reaffirms decision not to recommend

6 months ago

FDA rejects Astellas’ effort to support longer use of eye drug Izervay

6 months ago

Ahead of adcomm, FDA raises safety questions for AstraZeneca’s reversal agent for life-threatening bleeds

6 months ago

Chinese drugmaker receives FDA warning letter after management hindered inspection

6 months ago

BeiGene settles final suit over future Brukinsa generics

6 months ago

Lilly’s oral cardio drug that blocks lipids passes mid-stage test

6 months ago

J&J, Protagonist reveal two Phase 3 wins for oral IL-23 drug that's expected to be a blockbuster

6 months ago

Bristol Myers takes on autoimmune diseases with cell therapy, plus new data from Cabaletta and Kyverna

6 months ago

Bayer, Cytokinetics make a deal in Japan; Ex-Carmot CEO to run LB Pharmaceuticals

6 months ago

Lawmakers are poking holes in pharma's favorite new way to market medicines

6 months ago

Drugmakers 'not doing everything that they could' to widen global access, new report finds

6 months ago

Former NCI director teams up with serial entrepreneur for $70M VC fund targeting 'super-early' science

6 months ago

Merck finally has subcutaneous Keytruda results, and it's going to regulators

6 months ago

Incyte’s bet on Escient hits a snag as safety issues hamper Phase 2 chronic hives trial

6 months ago

Exclusive: Synapticure raises $25M for its approach to virtual neurodegenerative disease care

6 months ago

Exclusive: Jimini Health launches with $8M for AI-assisted therapy

6 months ago

Biogen, UCB detail response rates in Phase 3 lupus trial after surprising success

6 months ago

Vir, Bluejay invigorate hepatitis D space with new data

6 months ago

Rocket shares promising long-term results from rare heart disease gene therapy in small study

6 months ago

Neurogene patient had life-threatening side effect in Rett syndrome study

6 months ago

Syndax's Revuforj wins FDA approval in aggressive form of leukemia

6 months ago

CSL Behring will close California office as part of shrinking ex vivo work

6 months ago

First page Previous page 74 75 767778 79 80 Next page Last page